We report on 31 patients and 3 affected siblings (17 males and 17 females) from Southern France with McArdle disease (two from Spanish and three from Portuguese background). Molecular analysis revealed the presence of five previously described mutations: the common p.R50X nonsense mutation, the p.R94W and p.V456M missense mutations, the p.K609K conservative mutation which generates an aberrant splicing, and the p.K754fs frameshift mutation; and 10 new molecular defects: eight missense mutations at homozygous (p.G136D) or heterozygous state (p.T379M, p.G449R, p.T488I, p.R490Q, p.R570Q, p.R590H, and p.R715W), one nonsense mutation p.R650X and one deletion (p.delK170). Our results confirm that the p.R50X nonsense mutation is also the most common associated with myophosphorylase deficiency in the Southern French population: 21 of 25 French unrelated patients (15 homozygous and six heterozygous, i.e., 72% of the mutated alleles). Two patients, one from Algeria and one from Tunisia, were homozygous for a previously identified missense mutation p.V456M in a Moroccan subject. Our findings further demonstrate molecular heterogeneity of myophosphorylase deficiency, absence of genotype-phenotype correlation and expand the already crowded map of mutations within the myophosphorylase gene. Our study also provides evidence for increased medical interest of malignant hyperthermia susceptibility (MHS) because of 34 McArdle disease patients, three and two affected siblings were contracture-tested and found to be positive.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmd.2006.12.014DOI Listing

Publication Analysis

Top Keywords

myophosphorylase deficiency
12
mcardle disease
12
nonsense mutation
12
disease patients
8
southern france
8
absence genotype-phenotype
8
genotype-phenotype correlation
8
pr50x nonsense
8
missense mutations
8
mutation
6

Similar Publications

Background: Glycogen storage disease type 5 (McArdle disease) leads to a deficiency in the activity of myophosphorylase resulting in an impaired glucose utilization. The disease can be caused by a variety of mutations in the PYGM gene, and its typical clinical manifestation is muscles weakness within the first three decades of life.

Case Presentation: In this case report we present the diagnostic work-up of a physically active 78-year-old Caucasian patient suffering from a 2-year history of progressive camptocormia including clinical, radiologic, histological, and genetic tests.

View Article and Find Full Text PDF
Article Synopsis
  • Symptoms usually appear in late adolescence or early adulthood, leading to issues like rhabdomyolysis and elevated creatine kinase, with diagnosis confirmed through genetic testing.
  • Treatment involves a diet of slow-absorbing carbohydrates, regular low-intensity exercise, and potentially vitamin B6 and creatine, with a generally favorable prognosis if managed properly, but patients should avoid vigorous exercise to prevent complications.
View Article and Find Full Text PDF

Introduction: Whether cardiac impairment can be fully discarded in McArdle disease-the paradigm of "exercise intolerance," caused by inherited deficiency of the skeletal muscle-specific glycogen phosphorylase isoform ("myophosphorylase")-remains to be determined.

Methods: Eight patients with McArdle disease and seven age/sex-matched controls performed a 15-min moderate, constant-load cycle-ergometer exercise bout followed by a maximal ramp test. Electrocardiographic and two-dimensional transthoracic (for cardiac dimension's assessment) and speckle tracking (for left ventricular global longitudinal strain (GLS) assessments) echocardiographic evaluations were performed at baseline.

View Article and Find Full Text PDF
Article Synopsis
  • Glycogen storage disease type V is linked to mutations in the muscle glycogen phosphorylase gene and is treated with DL-3-hydroxybutyric acid combined with a modified Atkins diet.
  • A 13-year-old girl diagnosed with this disease showed improvements in muscle performance and reduced stiffness in her quadriceps after starting the treatment at age 16.
  • The study highlights the potential of DL-3-hydroxybutyric acid as an alternative energy source, suggesting that further research is necessary to confirm these findings and the utility of shear wave elastography in evaluating treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!